These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15988346)

  • 1. [Treatment of the psychological and behavioural disorders of Alzheimer's disease].
    Pancrazi MP; Metais P
    Presse Med; 2005 May; 34(9):667-72. PubMed ID: 15988346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy strategies in Alzheimer's disease].
    Lacomblez L
    Rev Prat; 1998 Nov; 48(17):1913-7. PubMed ID: 9854394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of psychiatric and behavioural symptoms in Alzheimer's disease].
    Lebert F; Pasquier F
    Rev Neurol (Paris); 2003 Sep; 159(8-9):825-30. PubMed ID: 13679730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of neuropsychiatric symptoms in Alzheimer's disease].
    Kaufer D
    Rev Neurol; 2002 Nov 1-15; 35(9):846-50. PubMed ID: 12436383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease.
    Miller LJ
    Consult Pharm; 2007 Sep; 22(9):754-62. PubMed ID: 18198970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 11. Medications for Alzheimer's disease. Benefits of currently approved drugs are limited, but research continues.
    Harv Ment Health Lett; 2011 Apr; 27(10):4-5. PubMed ID: 21786469
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.
    Borisovskaya A; Pascualy M; Borson S
    Curr Psychiatry Rep; 2014 Sep; 16(9):470. PubMed ID: 25023513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
    Lavretsky H; Nguyen LH
    Psychiatr Serv; 2006 May; 57(5):617-9. PubMed ID: 16675752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioural and psychological symptoms in dementia in Alzheimer's disease].
    Benoit M; Robert P
    Rev Prat; 2005 Nov; 55(17):1895-901. PubMed ID: 16396230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological and non-pharmacological treatment of Alzheimer's dementia].
    Wallesch CW
    MMW Fortschr Med; 2013 May; 155(8):60-2. PubMed ID: 24437141
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.